Use of Leukotriene C4 and D4 Antagonists
Leukotriene C4 and D4 Antagonists
Introduction
Purpose: Used to treat asthma.
Administration: Given orally, usually in the evening.
Key Drug: Montelukast
First clinically available leukotriene receptor antagonist.
Benefits:
Reduces requirement for glucocorticosteroids.
Improves symptoms in chronic asthma.
Useful for prophylaxis in:
Exercise-induced asthma.
Antigen-induced asthma.
Effectiveness:
Particularly effective in aspirin-sensitive asthma.
Mechanism: Arachidonic acid diversion from cyclo-oxygenase pathway (blocked by aspirin) to leukotriene formation via 5'-lipoxygenase.